Senator Stefano Supports Senate Passage of Compassionate Use of Medical Cannabis Act

Senator Pat Stefano (R-32) today voted for legislation that would allow Pennsylvania physicians to prescribe medicinal cannabis to their patients for certain health conditions. Senate Bill 3 was approved overwhelmingly by a bipartisan vote of 40-7.

Under Senate Bill 3, the non-smoked and non-hallucinogenic form of the medicine would be administered under strict regulation and under medical direction.

“Medical cannabis has proven effective across the nation to treat children with extreme seizure disorders and patients with other health conditions” Stefano said. “This bill will provide Pennsylvanians with much-needed access to the natural plant and give them with a resource that could help them regain their health.”

One of these children was Sydney Michaels, from Stefano’s district, who was the subject of articles in newspapers both locally and across the commonwealth.

“Last year Sydney’s mom, Julie, spoke to my Rotary group and I was deeply touched by her story,” Stefan said.   I am proud to support this legislation on behalf of Sydney, her family, and many other Pennsylvanians who will benefit from this treatment.

Senate Bill 3 would allow individuals who suffer from certain medical conditions to apply for a medical cannabis access card from the Department of Health. A licensed health care practitioner would be required to provide written certification in order for an application to the Department of Health to be considered.

The legislation creates a new Board of Medical Cannabis Licensing within the Department of State that will be responsible for regulating growers, dispensers and processors.

“The use of medical cannabis offers tremendous potential as a safe and effective treatment for many those suffering from chronic illness,” Stefano said. “This bill will provide access to medical cannabis in a safe and well-regulated manner.”

Senate Bill 3 now goes to the House of Representatives for consideration.

CONTACT: Ben Wren (717) 787-7175